Rilotumumab in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Clinical trial NCT01039207 · COMPLETED

Trial details

NCT number: NCT01039207
Sponsor: Gynecologic Oncology Group
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Fallopian Tube Carcinoma Recurrent Ovarian Carcinoma Recurrent Primary Peritoneal Carcinoma

Start date: 2010-10-01
Primary completion: 2012-07-01
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.